dc.creatorHosseini, Arezoo
dc.creatorHashemi, Vida
dc.creatorShomali, Navid
dc.creatorAsghari, Faezeh
dc.creatorGharibi, Tohid
dc.creatorAkbari, Morteza
dc.creatorGholizadeh, Saber
dc.creatorJafari, Abbas
dc.date.accessioned2020-11-04T16:00:20Z
dc.date.accessioned2022-09-23T18:25:43Z
dc.date.available2020-11-04T16:00:20Z
dc.date.available2022-09-23T18:25:43Z
dc.date.created2020-11-04T16:00:20Z
dc.identifier0753-3322
dc.identifierhttps://doi.org/10.1016/j.biopha.2020.110859
dc.identifierhttp://hdl.handle.net/20.500.12010/15316
dc.identifierhttps://doi.org/10.1016/j.biopha.2020.110859
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3500711
dc.description.abstractCoronaviruses (CoVs) are a member of the Coronaviridae family with positive-sense single- stranded RNA. In recent years, the CoVs have become a global problem to public health. The immune responses (innate and adaptive immunity) are essential for elimination and clearance of CoVs infections, however, uncontrolled immune responses can result in aggravating acute lung injury and significant immunopathology. Gaining profound understanding about the interaction between CoVs and the innate and adaptive immune systems could be a critical step in the field of treatment. In this review, we present an update on the host innate and adaptive immune responses against SARS-CoV, MERS-CoV and newly appeared SARS-CoV-2.
dc.languageeng
dc.publisherBiomedicine & Pharmacotherapy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectCOVID-19
dc.subjectInnate immune response
dc.subjectAdaptive immune response
dc.subjectMonoclonal antibody therapy
dc.subjectConvalescent plasma therapy
dc.titleInnate and adaptive immune responses against coronavirus


Este ítem pertenece a la siguiente institución